Retinal stroke: research models, targets and experimental drugs

References

• London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9:44–53. doi: 10.1038/nrneurol.2012.227
   PubMed Web of Science ®Google Scholar
• Vestergaard N, Cehofski LJ, Honoré B, et al. Animal models used to simulate retinal artery occlusion: a comprehensive review. Transl Vis Sci Technol. 2019;8(4):23. doi: 10.1167/tvst.8.4.23
   PubMed Web of Science ®Google Scholar
• Ørskov M, Vorum H, Larsen TB, et al. Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: a nationwide case-control study. Int Ophthalmol. 2023;43(3):817–824. doi: 10.1007/s10792-022-02483-3
   Web of Science ®Google Scholar
• Leavitt JA, Larson TA, Hodge DO, et al. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol. 2011;152(5):820–823.e2. doi: 10.1016/j.ajo.2011.05.005
   PubMed Web of Science ®Google Scholar
• Park SJ, Choi N-K, Seo KH, et al. Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011. Ophthalmol. 2014;121(10):1933–1938. doi: 10.1016/j.ophtha.2014.04.029
   PubMed Web of Science ®Google Scholar
• El-Saed A, Kuller LH, Newman AB, et al. Geographic variations in stroke incidence and mortality among older populations in four US communities. Stroke. 2006;37(8):1975–1979. doi: 10.1161/01.STR.0000231453.98473.67
   PubMed Web of Science ®Google Scholar
• Lane-Petter W. The place and importance of the experimental animal in research. Proc R Soc Med. 1972;65:343–344. doi: 10.1177/003591577206500414
   PubMedGoogle Scholar
• Fozzard HA. Validity of myocardial infarction models. Circulation. 1975;52:III131–146.
   PubMedGoogle Scholar
• Osborne NN, Casson RJ, Wood JPM, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23(1):91–147. doi: 10.1016/j.preteyeres.2003.12.001
   PubMed Web of Science ®Google Scholar
• San Cristóbal Epalza J, Palomares T, García-Alonso I, et al. Histological assessment of rat retinas with ischemia-reperfusion injury. Eur Surg Res. 2021;62:144–150. doi: 10.1159/000515832
   PubMed Web of Science ®Google Scholar
• Büchi ER, Suivaizdis I, Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica. 1991;203(3):138–147. doi: 10.1159/000310240
   PubMed Web of Science ®Google Scholar
• Hartsock MJ, Cho H, Wu L, et al. A mouse model of retinal ischemia-reperfusion injury through elevation of intraocular pressure. J Vis Exp. 2016;(113). doi: 10.3791/54065
   PubMed Web of Science ®Google Scholar
• Osborne NN, Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem Int. 1996;29(3):263–270. doi: 10.1016/0197-0186(96)00005-8
   PubMed Web of Science ®Google Scholar
• Safa R, Osborne NN. Retinas from albino rats are more susceptible to ischaemic damage than age-matched pigmented animals. Brain Res. 2000;862(1–2):36–42. doi: 10.1016/S0006-8993(00)02090-4
   PubMed Web of Science ®Google Scholar
• Gehlbach PL, Purple RL. A paired comparison of two models of experimental retinal ischemia. Curr Eye Res. 1994;13(8):597–602. doi: 10.3109/02713689408999893
   PubMed Web of Science ®Google Scholar
• Piras A, Gianetto D, Conte D, et al. Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure. PLoS One. 2011;6(7):e22514. doi: 10.1371/journal.pone.0022514
   PubMed Web of Science ®Google Scholar
• Pannicke T, Frommherz I, Biedermann B, et al. Differential effects of P2Y1 deletion on glial activation and survival of photoreceptors and amacrine cells in the ischemic mouse retina. Cell Death Dis. 2014;5(7):e1353. doi: 10.1038/cddis.2014.317
   PubMedGoogle Scholar
• Dreffs A, Lin C-M, Liu X, et al. All-trans-retinaldehyde contributes to retinal vascular permeability in ischemia reperfusion. Invest Ophthalmol Vis Sci. 2020;61(6):8. doi: 10.1167/iovs.61.6.8
   PubMed Web of Science ®Google Scholar
• Abcouwer SF, Shanmugam S, Muthusamy A, et al. Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury. J Neuroinflammation. 2021;18(1):186. doi: 10.1186/s12974-021-02237-5
   PubMed Web of Science ®Google Scholar
• Palmhof M, Lohmann S, Schulte D, et al. Fewer functional deficits and reduced cell death after ranibizumab treatment in a retinal ischemia model. Int J Mol Sci. 2018;19(6):1636. doi: 10.3390/ijms19061636
   PubMed Web of Science ®Google Scholar
• Chao H-M, Chuang M-J, Liu J-H, et al. Baicalein protects against retinal ischemia by antioxidation, antiapoptosis, downregulation of HIF-1α, VEGF, and MMP-9 and upregulation of HO-1. J Ocul Pharmacol Ther. 2013;29(6):539–549. doi: 10.1089/jop.2012.0179
   PubMed Web of Science ®Google Scholar
• Otsuka T, Shimazawa M, Inoue Y, et al. Astaxanthin protects against retinal damage: evidence from in vivo and in vitro retinal ischemia and reperfusion models. Curr Eye Res. 2016;41(11):1465–1472. doi: 10.3109/02713683.2015.1127392
   PubMed Web of Science ®Google Scholar
• Crespo-Garcia S, Reichhart N, Skosyrski S, et al. Individual and temporal variability of the retina after chronic bilateral common carotid artery occlusion (BCCAO). PLoS One. 2018;13(3):e0193961. doi: 10.1371/journal.pone.0193961
   PubMed Web of Science ®Google Scholar
• Rosenbaum DM, Rosenbaum PS, Singh M, et al. Functional and morphologic comparison of two methods to produce transient retinal ischemia in the rat. J Neuroophthalmol. 2001;21(1):62–68. doi: 10.1097/00041327-200103000-00015
   PubMed Web of Science ®Google Scholar
• Prasad SS, Kojic L, Wen YH, et al. Retinal gene expression after central retinal artery ligation: effects of ischemia and reperfusion. Invest Ophthalmol Vis Sci. 2010;51(12):6207–6219. doi: 10.1167/iovs.10-5632
   PubMed Web of Science ®Google Scholar
• Kalamkarov GR, Tsapenko IV, Zueva MV, et al. Experimental model of acute ischemia of the retina in rats. Bull Exp Biol Med. 2008;145:688–691. doi: 10.1007/s10517-008-0174-7
   PubMed Web of Science ®Google Scholar
• Mosinger JL, Price MT, Bai HY, et al. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol. 1991;113(1):10–17. doi: 10.1016/0014-4886(91)90140-8
   PubMed Web of Science ®Google Scholar
• Masuzawa K, Jesmin S, Maeda S, et al. A model of retinal ischemia-reperfusion injury in rats by subconjunctival injection of endothelin-1. Exp Biol Med (Maywood). 2006;231:1085–1089.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Piegors DJ, Heistad DD. Serotonin-induced constriction of ocular arteries in atherosclerotic monkeys. Implications for ischemic disorders of the retina and optic nerve head. Arch Ophthalmol. 1997;115:220–228. doi: 10.1001/archopht.1997.01100150222012
   PubMedGoogle Scholar
• Schroer H, Scheurer G, Behrens-Baumann W. Vascular occlusion of the retina–an experimental model. II. Platelet aggregates. Graefes Arch Clin Exp Ophthalmol. 1992;230:281–285. doi: 10.1007/BF00176305
   PubMed Web of Science ®Google Scholar
• Scheurer G, Praetorius G, Damerau B, et al. Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates. Graefes Arch Clin Exp Ophthalmol. 1992;230(3):275–280. doi: 10.1007/BF00176304
   PubMed Web of Science ®Google Scholar
• Gao Y, Wu D, Liu D, et al. Novel acute retinal artery ischemia and reperfusion model in nonhuman primates. Stroke. 2020;51(8):2568–2572. doi: 10.1161/STROKEAHA.119.028809
   PubMed Web of Science ®Google Scholar
• D’Onofrio PM, Koeberle PD. What can we learn about stroke from retinal ischemia models? Acta Pharmacol Sin. 2013;34(1):91–103. doi: 10.1038/aps.2012.165
   PubMed Web of Science ®Google Scholar
• Raber FP, Gmeiner FV, Dreyhaupt J, et al. Thrombolysis in central retinal artery occlusion: a retrospective observational study. J Neurol. 2022;270:891–897. doi: 10.1007/s00415-022-11439-7
   PubMed Web of Science ®Google Scholar
• Mac Grory B, Nackenoff A, Poli S, et al. Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis. Stroke. 2020;51(7):2018–2025. doi: 10.1161/STROKEAHA.119.028743
   PubMed Web of Science ®Google Scholar
• Sobol EK, Sakai Y, Wheelwright D, et al. Intra-arterial tissue Plasminogen Activator for central retinal artery occlusion. Clin Ophthalmol. 2021;15:601–608. doi: 10.2147/OPTH.S272126
   PubMed Web of Science ®Google Scholar
• Huang L, Wang Y, Zhang R. Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2022;261:103–113. doi: 10.1007/s00417-022-05797-1
   PubMed Web of Science ®Google Scholar
• Hu H, Zhang B, Zhao Y, et al. Efficacy of Intra-arterial thrombolysis for acute central retinal artery occlusion: a meta-analysis. Eur Neurol. 2022;85(3):186–194. doi: 10.1159/000520443
   PubMed Web of Science ®Google Scholar
• Kadonosono K, Yamane S, Inoue M, et al. Intra-retinal arterial cannulation using a microneedle for central retinal artery occlusion. Sci Rep. 2018;8(1):1360. doi: 10.1038/s41598-018-19747-7
   PubMed Web of Science ®Google Scholar
• Man V, Hecht I, Talitman M, et al. Treatment of retinal artery occlusion using transluminal Nd: YAG laser: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2017;255:1869–1877. doi: 10.1007/s00417-017-3777-8
   PubMed Web of Science ®Google Scholar
• Wen X, Yuan M, Li C, et al. Effect of vitrectomy with intrasurgical regulation of intraocular pressure in a rabbit model of central retinal artery occlusion. Exp Eye Res. 2019;189:107779. doi: 10.1016/j.exer.2019.107779
   PubMed Web of Science ®Google Scholar
• Altun A, Giusti C. Intraoperative cycling pressure variation in the treatment of central retinal artery occlusion. Case Rep Ophthalmol Med. 2021;2021:1–4. doi: 10.1155/2021/6649657
   Web of Science ®Google Scholar
• Di Vincenzo H, Kauert A, Martiano D, et al. Efficacy and safety of a standardized hyperbaric oxygen therapy protocol for retinal artery occlusion. Undersea Hyperb Med. 2022;49:495–505. doi: 10.22462/07.08.2022.9
   PubMed Web of Science ®Google Scholar
• Kim Y-S, Nam M-S, Park EJ, et al. The effect of adjunctive hyperbaric oxygen therapy in patients with central retinal artery occlusion. Undersea Hyperb Med. 2020;47:57–64. doi: 10.22462/01.03.2020.7
   PubMed Web of Science ®Google Scholar
• Rosignoli L, Chu ER, Carter JE, et al. The effects of hyperbaric oxygen therapy in patients with central retinal artery occlusion: a Retrospective study, systematic review, and meta-analysis. Korean J Ophthalmol. 2022;36:108–113. doi: 10.3341/kjo.2021.0130
   PubMedGoogle Scholar
• Klemm P, Hurst J, Dias Blak M, et al. Hypothermia protects retinal ganglion cells against hypoxia-induced cell death in a retina organ culture model. Clin Exp Ophthalmol. 2019;47(8):1043–1054. doi: 10.1111/ceo.13565
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Suzuki T, Takahashi K, et al. Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina. Exp Eye Res. 2018;171:30–36. doi: 10.1016/j.exer.2018.03.008
   PubMed Web of Science ®Google Scholar
• Ikeda HO, Muraoka Y, Hata M, et al. Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: an open-label, non-randomized, first-in-humans, phase 1/2 trial. PLoS One. 2020;15(2):e0229068. doi: 10.1371/journal.pone.0229068
   PubMed Web of Science ®Google Scholar
• Hoyer C, Winzer S, Matthé E, et al. Current diagnosis and treatment practice of central retinal artery occlusion: results from a survey among German stroke units. Neurol Res Pract. 2022;4(1):30. doi: 10.1186/s42466-022-00193-w
   PubMedGoogle Scholar
• Ardila Jurado E, Sturm V, Brugger F, et al. Central retinal artery occlusion: current practice, awareness and prehospital delays in Switzerland. Front Neurol. 2022;13:888456. doi: 10.3389/fneur.2022.888456
   PubMed Web of Science ®Google Scholar
• Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion: a scientific statement from the American heart association. Stroke. 2021;52(6):e282–94. doi: 10.1161/STR.0000000000000366
   PubMed Web of Science ®Google Scholar
• Lee KE, Tschoe C, Coffman SA, et al. Management of acute central retinal artery occlusion, a “retinal stroke”: an institutional series and literature review. J Stroke Cerebrovasc Dis. 2021;30(2):105531. doi: 10.1016/j.jstrokecerebrovasdis.2020.105531
   PubMed Web of Science ®Google Scholar
• Dumitrascu OM, Newman NJ, Biousse V. Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuroophthalmol. 2020;40(3):333–345. doi: 10.1097/WNO.0000000000001027
   PubMed Web of Science ®Google Scholar